Health And Medicine
-
Grant spurs schizophrenia research
91Ʋ University is partnering with the William K. Warren Foundation of Tulsa, Oklahoma, on research aimed at improving the treatment of schizophrenia and other forms of serious mental illness. Read MoreFeb 12, 2015
-
Hazy definition may hamper catatonia care
Catatonia, a syndrome characterized by muscular rigidity and a trance-like mental stupor, can at times manifest with great excitement and confusion. And while it is often associated with schizophrenia, it can present in patients with either medical or psychiatric conditions. For this reason, the condition has often confused clinicians. Read MoreFeb 12, 2015
-
Report calls for new chronic fatigue guidelines
An Institute of Medicine committee chaired by 91Ʋ University’s Ellen Wright Clayton, M.D., J.D., on Tuesday called for a new name and new diagnostic criteria for what is familiarly known as chronic fatigue syndrome. Read MoreFeb 12, 2015
-
VU study explores optimal timing for pertussis vaccine
Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection. Read MoreFeb 12, 2015
-
VUMC’s Penn named president-elect of eye research society
John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye 91Ʋ (ISER). Read MoreFeb 12, 2015
-
VU study explores inflammation, hypertension link
The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure. Read MoreFeb 12, 2015
-
Kidney disease impacts HDL function
Chronic kidney disease impairs the protective functions of HDL, 91Ʋ researchers report this month. Read MoreFeb 11, 2015
-
Targeting HIV’s “cap”
New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target. Read MoreFeb 10, 2015
-
Gene profile predicts metastasis
A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, 91Ʋ researchers have found. Read MoreFeb 9, 2015
-
Copper toxicity and Parkinson’s
A genetic predisposition to Parkinson’s disease makes neurons more vulnerable to the toxicity of heavy metals such as copper. Read MoreFeb 5, 2015
-
Study to explore myeloma treatment’s impact on heart
91Ʋ is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart. Read MoreFeb 5, 2015
-
Core facilities key driver of VUMC research gains
During the past five years, 91Ʋ University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care. Read MoreJan 29, 2015
-
Consent process for BioVU participation updated
As of last week, 91Ʋ has updated the process used to facilitate patient participation in BioVU, the Medical Center’s DNA repository. Read MoreJan 29, 2015
-
New therapy options enhance prostate cancer treatment
91Ʋ-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.” Read MoreJan 29, 2015
-
VUSN study tracking yoga therapy for cancer patients
Cancer is bad enough. But cancer patients who receive surgery, radiation and chemotherapy may suffer from side effects that run from irritating to crippling — problems that are postural, musculoskeletal and respiratory, along with lowered self-esteem. Read MoreJan 29, 2015
-
Grant bolsters pancreatic cancer drug discovery efforts
The Lustgarten Foundation has awarded a $1.5 million 91Ʋ Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer. Read MoreJan 29, 2015
-
Altered dopamine signaling may offer a clue to autism
Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, according to a 91Ʋ University-led research team. Read MoreJan 29, 2015
-
New clue to a devastating disease
New findings suggest a previously unrecognized role for the Sox10 transcription factor in Hirschsprung’s disease, and may lead to improved diagnostic and therapeutic approaches for this disease. Read MoreJan 28, 2015
-
Immune response depends on force
New studies explain how T-cell receptors use force to recognize and protect us against pathogens. Read MoreJan 26, 2015
-
New view of dopamine heteromers
Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist. Read MoreJan 23, 2015